+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Influenza Vaccine Market Research Report by Age Group, by Vaccine Type, by Administration Rout, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5012972
  • Report
  • July 2020
  • Region: Global
  • 225 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Influenza Vaccine Market to Grow USD 7,321.79 Million by 2025, at a CAGR of 4.68%

FEATURED COMPANIES

  • Abbott Biologicals B.V.
  • BioDiem
  • Emergent BioSolutions
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Sanofi S.A.
  • MORE
The Global Influenza Vaccine Market is expected to grow from USD 5,563.37 Million in 2019 to USD 7,321.79 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.68%.

Market Segmentation & Coverage:

This research report categorizes the Influenza Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Age Group, the Influenza Vaccine Market studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination.

Based on Vaccine Type, the Influenza Vaccine Market studied across Inactivated, Live Attenuated, and Recombinant.

Based on Administration Rout, the Influenza Vaccine Market studied across Intramuscular and Intranasal.

Based on Distribution Channel, the Influenza Vaccine Market studied across Hospital & Clinic, Medical Office, Retail Pharmacy, and Urgent Care Unit.

Based on Geography, the Influenza Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Influenza Vaccine Market including Abbott Biologicals B.V., AstraZeneca, BioDiem, BiondVax Pharmaceuticals Ltd., Daiichi-Sankyo, Emergent BioSolutions, Fluart Innovative Vaccines Kft., GAMMA VACCINES PTY LTD., GlaxoSmithKline plc, Merck & Co., Inc., Mylan N.V., Pfizer Inc., Sanofi S.A., Seqirus GmbH, and Serum Institute of India Private Limited.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Influenza Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Influenza Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Influenza Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Influenza Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Influenza Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Influenza Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Influenza Vaccine Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Biologicals B.V.
  • BioDiem
  • Emergent BioSolutions
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Age Group Outlook
3.3. Vaccine Type Outlook
3.4. Administration Rout Outlook
3.5. Distribution Channel Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing prevalence of respiratory disorders
5.2.2. Immunization as a major public health measure for the prevention of influenza virus infection
5.2.3. Clinical trials and vaccines developments in pipeline for seasonal influenzas
5.2.4. Government initiatives supporting respiratory health
5.3. Restraints
5.3.1. Lack of inadequate delivery infrastructure & limited awareness
5.4. Opportunities
5.4.1. Increasing R&D expenditure by leading companies
5.4.2. Increase vaccine availability through reselling collaborations
5.4.3. Several vaccine candidates under development against animal influenza A viruses
5.5. Challenges
5.5.1. Consumer trust & confidence in respiratory disease vaccination
5.5.2. Continues changes in strains challenges vaccine research and development

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations
6.3.1. COVID: Eye on Proactive Vaccine Development
6.3.2. Shift to Retail Pharmacies for Immunizations

7. Global Influenza Vaccine Market, By Age Group
7.1. Introduction
7.2. Adolescent Vaccination
7.3. Adult Vaccination
7.4. Infant Vaccination

8. Global Influenza Vaccine Market, By Vaccine Type
8.1. Introduction
8.2. Inactivated
8.3. Live Attenuated
8.4. Recombinant

9. Global Influenza Vaccine Market, By Administration Rout
9.1. Introduction
9.2. Intramuscular
9.3. Intranasal

10. Global Influenza Vaccine Market, By Distribution Channel
10.1. Introduction
10.2. Hospital & Clinic
10.3. Medical Office
10.4. Retail Pharmacy
10.5. Urgent Care Unit

11. Global Influenza Vaccine Market, By Geography
11.1. Introduction
11.2. Americas
11.2.1. Argentina
11.2.2. Brazil
11.2.3. Canada
11.2.4. Mexico
11.2.5. United States
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Indonesia
11.3.5. Japan
11.3.6. Malaysia
11.3.7. Philippines
11.3.8. South Korea
11.3.9. Thailand
11.4. Europe, Middle East & Africa
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Netherlands
11.4.5. Qatar
11.4.6. Russia
11.4.7. Saudi Arabia
11.4.8. South Africa
11.4.9. Spain
11.4.10. United Arab Emirates
11.4.11. United Kingdom

12. Competitive Strategic Window
12.1. Introduction
12.2. Competitive Strategic Window, by Age Group
12.3. Competitive Strategic Window, by Vaccine Type
12.4. Competitive Strategic Window, by Administration Rout
12.5. Competitive Strategic Window, by Distribution Channel
12.6. Competitive Strategic Window, by Geography

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Biologicals B.V.
14.2. AstraZeneca
14.3. BioDiem
14.4. BiondVax Pharmaceuticals Ltd.
14.5. Daiichi-Sankyo
14.6. Emergent BioSolutions
14.7. Fluart Innovative Vaccines Kft.
14.8. GAMMA VACCINES PTY LTD.
14.9. GlaxoSmithKline plc
14.10. Merck & Co., Inc.
14.11. Mylan N.V.
14.12. Pfizer Inc.
14.13. Sanofi S.A.
14.14. Seqirus GmbH
14.15. Serum Institute of India Private Limited

15. Appendix
15.1. Discussion Guide
15.2. Edition Details
15.3. License Details
15.4. Pricing Details

LIST OF FIGURES
FIGURE 1. GLOBAL INFLUENZA VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INFLUENZA VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2019 VS 2025 (USD MILLION)
FIGURE 7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INFLUENZA VACCINE MARKET, BY TYPE
FIGURE 10. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 11. GLOBAL INFLUENZA VACCINE MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 12. GLOBAL INFLUENZA VACCINE MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL INFLUENZA VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2019 VS 2025 (USD MILLION)
FIGURE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2019 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 19. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 20. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2025
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 27. GLOBAL INFLUENZA VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 28. GLOBAL INFLUENZA VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT VACCINATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INFANT VACCINATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INTRANASAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL & CLINIC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY MEDICAL OFFICE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY URGENT CARE UNIT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 19. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 20. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 21. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 22. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 23. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 24. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 25. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 26. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 27. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 28. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 29. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 30. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 31. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 32. CANADA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 33. CANADA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 34. CANADA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 35. CANADA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 36. MEXICO INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 37. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 38. MEXICO INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 39. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 40. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 41. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 42. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 43. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 44. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 45. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 46. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 47. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 48. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 49. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 50. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 51. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 52. AUSTRALIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 53. CHINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 54. CHINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 55. CHINA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 56. CHINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 57. INDIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 58. INDIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 59. INDIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 60. INDIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 61. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 62. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 63. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 64. INDONESIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 65. JAPAN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 66. JAPAN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 67. JAPAN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 68. JAPAN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 69. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 70. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 71. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 72. MALAYSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 73. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 74. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 75. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 76. PHILIPPINES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 77. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 78. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 79. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 80. SOUTH KOREA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 81. THAILAND INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 82. THAILAND INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 83. THAILAND INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 84. THAILAND INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 90. FRANCE INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 91. FRANCE INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 92. FRANCE INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 93. FRANCE INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 94. GERMANY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 95. GERMANY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 96. GERMANY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 97. GERMANY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 98. ITALY INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 99. ITALY INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 100. ITALY INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 101. ITALY INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 102. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 103. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 104. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 105. NETHERLANDS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 106. QATAR INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 107. QATAR INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 108. QATAR INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 109. QATAR INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 110. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 111. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 112. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 113. RUSSIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 114. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 115. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 116. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 117. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 118. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 119. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 120. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 121. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 122. SPAIN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 123. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 124. SPAIN INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 125. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 130. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 131. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
TABLE 132. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY ADMINISTRATION ROUT, 2017-2025 (USD MILLION)
TABLE 133. UNITED KINGDOM INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 134. GLOBAL INFLUENZA VACCINE MARKET: SCORES
TABLE 135. GLOBAL INFLUENZA VACCINE MARKET: BUSINESS STRATEGY
TABLE 136. GLOBAL INFLUENZA VACCINE MARKET: PRODUCT SATISFACTION
TABLE 137. GLOBAL INFLUENZA VACCINE MARKET: RANKING
TABLE 138. GLOBAL INFLUENZA VACCINE MARKET: MERGER & ACQUISITION
TABLE 139. GLOBAL INFLUENZA VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. GLOBAL INFLUENZA VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. GLOBAL INFLUENZA VACCINE MARKET: INVESTMENT & FUNDING
TABLE 142. GLOBAL INFLUENZA VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 143. GLOBAL INFLUENZA VACCINE MARKET: EDITION DETAILS
TABLE 144. GLOBAL INFLUENZA VACCINE MARKET: LICENSE DETAILS
TABLE 145. GLOBAL INFLUENZA VACCINE MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Biologicals B.V.
  • AstraZeneca
  • BioDiem
  • BiondVax Pharmaceuticals Ltd.
  • Daiichi-Sankyo
  • Emergent BioSolutions
  • Fluart Innovative Vaccines Kft.
  • GAMMA VACCINES PTY LTD.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus GmbH
  • Serum Institute of India Private Limited
Note: Product cover images may vary from those shown
Adroll
adroll